Logo image of VIGL

VIGIL NEUROSCIENCE INC (VIGL) Stock Overview

NASDAQ:VIGL - US92673K1088 - Common Stock

8.05 USD
0 (0%)
Last: 8/4/2025, 8:00:01 PM
8.09 USD
+0.04 (+0.5%)
After Hours: 8/4/2025, 8:00:01 PM

VIGL Key Statistics, Chart & Performance

Key Statistics
52 Week High8.1
52 Week Low1.31
Market Cap375.69M
Shares46.67M
Float43.23M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.09
PEN/A
Fwd PEN/A
Earnings (Next)11-03 2025-11-03
IPO01-07 2022-01-07
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


VIGL short term performance overview.The bars show the price performance of VIGL in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 50 100 150 200

VIGL long term performance overview.The bars show the price performance of VIGL in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 100 150

The current stock price of VIGL is 8.05 USD. In the past month the price increased by 0.75%. In the past year, price increased by 170.13%.

VIGIL NEUROSCIENCE INC / VIGL Daily stock chart

VIGL Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 19.87 371.68B
AMGN AMGEN INC 13.19 154.89B
GILD GILEAD SCIENCES INC 14.6 140.17B
VRTX VERTEX PHARMACEUTICALS INC 23.08 100.25B
REGN REGENERON PHARMACEUTICALS 12.72 61.55B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 58.53B
ARGX ARGENX SE - ADR 76.83 43.59B
ONC BEONE MEDICINES LTD-ADR 6.16 36.38B
INSM INSMED INC N/A 28.77B
BNTX BIONTECH SE-ADR N/A 24.04B
NTRA NATERA INC N/A 23.09B
BIIB BIOGEN INC 8.26 19.38B

About VIGL

Company Profile

VIGL logo image Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. The company is headquartered in Watertown, Massachusetts and currently employs 69 full-time employees. The company went IPO on 2022-01-07. The firm is focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. The company is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in its efforts to develop precision-based therapies to improve the lives of patients and their families. Its lead clinical candidate, VGL101 (iluzanebart), is a fully human monoclonal antibody TREM2 agonist that is being studied in a Phase 2 proof-of-concept trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. The firm is also developing VG-3927, its orally available small molecule TREM2 agonist program to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer’s disease in genetically defined subpopulations.

Company Info

VIGIL NEUROSCIENCE INC

100 Forge Road, Suite 700

Watertown MASSACHUSETTS US

Employees: 69

VIGL Company Website

VIGL Investor Relations

Phone: 18572544445

VIGIL NEUROSCIENCE INC / VIGL FAQ

What is the stock price of VIGIL NEUROSCIENCE INC today?

The current stock price of VIGL is 8.05 USD.


What is the ticker symbol for VIGIL NEUROSCIENCE INC stock?

The exchange symbol of VIGIL NEUROSCIENCE INC is VIGL and it is listed on the Nasdaq exchange.


On which exchange is VIGL stock listed?

VIGL stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for VIGIL NEUROSCIENCE INC stock?

13 analysts have analysed VIGL and the average price target is 8.16 USD. This implies a price increase of 1.37% is expected in the next year compared to the current price of 8.05. Check the VIGIL NEUROSCIENCE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is VIGIL NEUROSCIENCE INC worth?

VIGIL NEUROSCIENCE INC (VIGL) has a market capitalization of 375.69M USD. This makes VIGL a Small Cap stock.


How many employees does VIGIL NEUROSCIENCE INC have?

VIGIL NEUROSCIENCE INC (VIGL) currently has 69 employees.


What are the support and resistance levels for VIGIL NEUROSCIENCE INC (VIGL) stock?

VIGIL NEUROSCIENCE INC (VIGL) has a support level at 8.04 and a resistance level at 8.05. Check the full technical report for a detailed analysis of VIGL support and resistance levels.


Should I buy VIGIL NEUROSCIENCE INC (VIGL) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does VIGIL NEUROSCIENCE INC (VIGL) stock pay dividends?

VIGL does not pay a dividend.


When does VIGIL NEUROSCIENCE INC (VIGL) report earnings?

VIGIL NEUROSCIENCE INC (VIGL) will report earnings on 2025-11-03.


What is the Price/Earnings (PE) ratio of VIGIL NEUROSCIENCE INC (VIGL)?

VIGIL NEUROSCIENCE INC (VIGL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.09).


What is the Short Interest ratio of VIGIL NEUROSCIENCE INC (VIGL) stock?

The outstanding short interest for VIGIL NEUROSCIENCE INC (VIGL) is 1.31% of its float. Check the ownership tab for more information on the VIGL short interest.


VIGL Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to VIGL. When comparing the yearly performance of all stocks, VIGL is one of the better performing stocks in the market, outperforming 98.76% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

VIGL Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to VIGL. VIGL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VIGL Financial Highlights

Over the last trailing twelve months VIGL reported a non-GAAP Earnings per Share(EPS) of -2.09. The EPS increased by 1.42% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -80.94%
ROE -133.18%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-7.69%
Sales Q2Q%N/A
EPS 1Y (TTM)1.42%
Revenue 1Y (TTM)N/A

VIGL Forecast & Estimates

13 analysts have analysed VIGL and the average price target is 8.16 USD. This implies a price increase of 1.37% is expected in the next year compared to the current price of 8.05.


Analysts
Analysts52.31
Price Target8.16 (1.37%)
EPS Next Y20.49%
Revenue Next YearN/A

VIGL Ownership

Ownership
Inst Owners67.08%
Ins Owners0.51%
Short Float %1.31%
Short Ratio0.28